large_intestinal_mucosa

Elucidation of pathogenesis of ulcerative colitis and Crohn’s disease: Leading to new treatment methods for refractory inflammatory bowel diseases -- Kindai University

- The team discovered that type I interferon, one of the inflammatory cytokines, is involved in exacerbation of inflammatory bowel disease. - An enzyme that inhibits the activity of type I interferons has been identified as a novel therapeutic target for inflammatory bowel disease. - This research offers insights into the development of new treatments for intractable inflammatory bowel disease.